Advances in genomics studies have revealed new etiological and somatic genetic events that drive breast cancer pathogenesis.
Long-term effects seen beyond FY2018 if reduced federal spending slows down the transformation of research into clinical practice
Precision Medicine company Progenity, a developer of both diagnostic and therapeutic platforms, announced results from three studies that represent potential breakthrough methods for diagnosing,...
Researchers report that approaches using precision medicine for cancer treatment, showed improved response and longer periods of remission.
Companies say Genoptix interested in 'alternative options' after fewer Rosetta shareholders approve the deal than needed for completion
The company will use the capital to fund further development of its diagnostic and therapeutic platform focused on gastrointestinal diseases
To date, training programs in molecular diagnostics have been proliferating beyond anyone’s ability to define a curriculum. But at least one organization is trying...
Scientists have mapped the genetic diversity of microbes residing in the human gut and mouth.
An international research effort has identified the first common genetic risk factors for autism spectrum disorder.
Sangamo Therapeutics treats the first patient in a Phase I/II study of its zinc finger nuclease candidate SB-913, designed to treat MPS II.